We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Strados Labs Stock

Invest in or calculate the value of your shares in Strados Labs or other pre-IPO companies through EquityZen's platform.

Get Started

Strados Labs Stock

Strados Labs innovates respiratory monitoring using smart biosensors and artificial intelligence.

About Strados Labs Stock

Founded

2016

Headquarters

Philadelphia, PA, US

Industries

Artificial Intelligence, Software, Data and Analytics

Strados Labs is a medical technology company that innovates respiratory monitoring using smart biosensors and artificial intelligence. The company specializes in advancing respiratory health management using clinical-grade biosensors and intelligent software. It connects people with real-time respiratory monitoring using a wearable device and connected mobile platform so they can quantify their health and make more informed decisions. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

Strados Labs Management

Leadership team at Strados Labs

CEO & Founder

Nick Delmonico

Chief Product Officer (CPO) & Co-Founder

Richard Powers

Locked Features

Join now and verify your accreditation status to gain access to:

  • Strados Labs Current Valuation
  • Strados Labs Stock Price
  • Strados Labs Management
  • Available deals in Strados Labs and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Strados Labs Cap Table and Funding History by Share Class and Liquidity Preferences
    • Strados Labs Revenue and Financials
    • Strados Labs Highlights
    • Strados Labs Business Model
    • Strados Labs Risk Factors
  • Strados Labs Research Report from SACRA Research
Join Now

Trading Strados Labs Stock

How to invest in Strados Labs stock?

Accredited investors can buy pre-IPO stock in companies like Strados Labs through EquityZen funds. These investments are made available by existing Strados Labs shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.

How to sell Strados Labs stock?

Shareholders can sell their Strados Labs stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Strados Labs